39819-39-1

Basic information

• Product Name: 2-PHENYL-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 2-PHENYL-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER;2-Phenyl-4-oxazolecarboxylic acid ethyl ester;ethyl 2-phenyloxazole-4-carboxylate;Ethyl 2-phenyl-1,3-oxazole-4-carboxylate
• CAS NO: 39819-39-1
• Molecular Formula: C₁₂H₁₁NO₃
• Molecular Weight: 217.22
• EINECS: 604-604-1
• Mol File: 39819-39-1.mol
• Article Data: 31

Chemical Properties

• Boiling Point: 340 °C at 760 mmHg
• Flash Point: 159.4 °C
• Appearance: /
• Density: 1.173 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-PHENYL-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PHENYL-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(39819-39-1)
• EPA Substance Registry System: 2-PHENYL-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(39819-39-1)

Safety Data

• Hazardous Substances Data: 39819-39-1(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron, 49, p. 5445, 1993 DOI: 10.1016/S0040-4020(01)87261-6

Upstream product

• 617-35-6 2-oxo-propionic acid ethyl ester 
• 55-21-0 benzamide 
• 23012-14-8 oxazole-4-carboxylic acid ethyl ester 
• 591-50-4 iodobenzene 
• 70-23-5 ethyl Bromopyruvate 
• 15933-07-0 Ethyl 2-oxobutanoate 
• 80548-05-6 2-benzoylamino-3-oxo-propionic acid ethyl ester 
• 1499-53-2 ethyl hippurate 
• 108-90-7 chlorobenzene 
• 108-86-1 bromobenzene 
• 1236209-05-4 ethyl 5-(methylthio)-2-phenyloxazole-4-carboxylate 
• 2446-52-8 ethyl N-hydroxyiminobenzoate 
• 7340-17-2 ethyl N-hydroxybenzimidate 
• 93-89-0 benzoic acid ethyl ester 

Downstream Products

• 23012-16-0 2-phenyl-1,3-oxazole-4-carboxylic acid 
• 460081-28-1 5-bromo-2-phenyl-oxazole-4-carboxylic acid ethyl ester 
• 18735-78-9 2,5-diphenyloxazole-4-carboxylic acid 
• 573-34-2 2,4,5-triphenyloxazole 
• 93729-29-4 ethyl 2,5-diphenyloxazole-4-carboxylate 
• 7007-08-1 4-bromo-2,5-diphenyloxazole 
• 113923-95-8 2,5-diphenyl-4-vinyloxazole 
• 70216-32-9 5-(3,4-dimethoxyphenyl)-2-phenyl-1,3-oxazole 
• 99970-81-7 2-phenyl-4-thiazol-2-yl-oxazole 
• 100382-05-6 4-(4-methyl-thiazol-2-yl)-2-phenyl-oxazole 
• 101874-63-9 2-phenyl-4-(4-phenyl-thiazol-2-yl)-oxazole 
• 101936-28-1 2-phenyl-4-(4-p-tolyl-thiazol-2-yl)-oxazole 
• 101606-68-2 4-[4-(4-chloro-phenyl)-thiazol-2-yl]-2-phenyl-oxazole 
• 101606-57-9 4-[4-(4-bromo-phenyl)-thiazol-2-yl]-2-phenyl-oxazole 

Relevant articles and documents

Rational Design, Synthesis and Evaluation of Oxazolo[4,5-c]-quinolinone Analogs as Novel Interleukin-33 Inhibitors

Interleukin-33 (IL-33) is an epithelial-derived cytokine that plays an important role in immune-mediated diseases such as asthma, atopic dermatitis, and rheumatoid arthritis. Although IL-33 is considered a potential target for the treatment of allergy-rel

NOVEL QUINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES SUCH AS ASTHMA OR ATOPIC DERMATITIS INCLUDING THE QUINOLINONE DERIVATIVE AS ACTIVE INGREDIENT

The present invention relates to anovel quinolinone derivative compound that regulates intracellular signal transduction mediated by TSLP and IL-33 to exhibit efficacy in preventing or treating allergic diseases such as asthma or atopic dermatitis. The qu

Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)

Lipoxins (LXs) are endogenously generated eicosanoids with potent bio-actions consistent with attenuation of inflammation. The costly synthesis and metabolic instability of LXs may limit their therapeutic potential. Here we report the synthesis and charac